These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 23412014)

  • 21. Familial and acquired long qt syndrome and the cardiac rapid delayed rectifier potassium current.
    Witchel HJ; Hancox JC
    Clin Exp Pharmacol Physiol; 2000 Oct; 27(10):753-66. PubMed ID: 11022966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Electropharmacological assessment of the risk of drug-induced long-QT syndrome using native cardiac cells and cultured cells expressing HERG channels].
    Nakaya H
    Nihon Yakurigaku Zasshi; 2003 Jun; 121(6):384-92. PubMed ID: 12835532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Torsades de pointes].
    Guize L; Iliou MC; Bayet G; Lavergne T; Le Heuzey JY
    Arch Mal Coeur Vaiss; 1993 May; 86(5 Suppl):769-76. PubMed ID: 8267505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The inherited long QT syndrome: from ion channel to bedside.
    Vincent GM; Timothy K; Fox J; Zhang L
    Cardiol Rev; 1999; 7(1):44-55. PubMed ID: 10348966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Torsade de pointes.
    El-Sherif N; Turitto G
    Curr Opin Cardiol; 2003 Jan; 18(1):6-13. PubMed ID: 12496496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. QT interval prolongation and torsade de pointes.
    Patanè S; Marte F; Di Bella G
    Int J Cardiol; 2009 Jan; 131(2):e51-3. PubMed ID: 17689729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Takotsubo cardiomyopathy as a potential cause of long QT syndrome and torsades de pointes.
    Ghosh S; Apte P; Maroz N; Broor A; Zeineh N; Khan IA
    Int J Cardiol; 2009 Aug; 136(2):225-7. PubMed ID: 18617280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.
    Topilski I; Rogowski O; Rosso R; Justo D; Copperman Y; Glikson M; Belhassen B; Hochenberg M; Viskin S
    J Am Coll Cardiol; 2007 Jan; 49(3):320-8. PubMed ID: 17239713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventing torsades de pointes by careful cardiac monitoring in hospital settings.
    Sommargren CE; Drew BJ
    AACN Adv Crit Care; 2007; 18(3):285-93. PubMed ID: 18019519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of QTc and Risk of Torsades de Pointes in Ventricular Conduction Delay and Pacing: A Review of the Literature and Call to Action.
    Funk MC; Cates KW; Rajagopalan A; Lane CE; Lou J
    J Acad Consult Liaison Psychiatry; 2021; 62(5):501-510. PubMed ID: 34489062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dofetilide-induced long QT and torsades de pointes.
    Aktas MK; Shah AH; Akiyama T
    Ann Noninvasive Electrocardiol; 2007 Jul; 12(3):197-202. PubMed ID: 17617063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes?
    Samuelov-Kinori L; Kinori M; Kogan Y; Swartzon M; Shalev H; Guy D; Ferenidou F; Mashav N; Sadeh B; Atzmony L; Kliuk-Ben-Basat O; Steinvil A; Justo D
    J Electrocardiol; 2009; 42(4):353-357.e1. PubMed ID: 19261294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Torsade de pointes: the clinical considerations.
    Gowda RM; Khan IA; Wilbur SL; Vasavada BC; Sacchi TJ
    Int J Cardiol; 2004 Jul; 96(1):1-6. PubMed ID: 15203254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-induced torsade de pointes: from molecular biology to bedside.
    Tamargo J
    Jpn J Pharmacol; 2000 May; 83(1):1-19. PubMed ID: 10887935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Torsades de pointes complicating complete heart block with QT interval prolongation.
    Stankovic I; Putnikovic B; Neskovic AN
    Acta Cardiol; 2016; 71(5):627. PubMed ID: 27695027
    [No Abstract]   [Full Text] [Related]  

  • 36. Noninvasive cardiac activation imaging of ventricular arrhythmias during drug-induced QT prolongation in the rabbit heart.
    Han C; Pogwizd SM; Killingsworth CR; Zhou Z; He B
    Heart Rhythm; 2013 Oct; 10(10):1509-15. PubMed ID: 23773986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of drug induced QT interval prolongation.
    Ponte ML; Keller GA; Di Girolamo G
    Curr Drug Saf; 2010 Jan; 5(1):44-53. PubMed ID: 20210718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [CME ECG 66/Answers: Torsade de Pointes: The Danger of a Rotating Heart Axis].
    Markendorf S; Saguner AM; Brunckhorst C
    Praxis (Bern 1994); 2020; 109(13):1035-1038. PubMed ID: 33050812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement and Management of QT Interval Prolongation for General Physicians.
    Indraratna P; Tardo D; Delves M; Szirt R; Ng B
    J Gen Intern Med; 2020 Mar; 35(3):865-873. PubMed ID: 31654357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenosine induced torsades de pointes in a child with congenital long QT syndrome.
    Celiker A; Tokel K; Cil E; Ozkutlu S; Ozme S
    Pacing Clin Electrophysiol; 1994 Nov; 17(11 Pt 1):1814-7. PubMed ID: 7838793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.